Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Apr;144(4):807–819.

Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.

M Susani 1, M Schulze 1, M Exner 1, D Kerjaschki 1
PMCID: PMC1887236  PMID: 8160779

Abstract

Passive Heymann nephritis is an experimental rat model of human membranous nephropathy induced by injection of antisera against crude renal cortical fractions such as Fx1A or rat tubular microvilli. This results in the formation of subepithelial immune deposits, the activation of the C5b-9 membrane attack complex of complement, and severe proteinuria. While the formation of immune deposits is attributed to in situ immune complex formation with antibodies specific for the gp330-Heymann nephritis antigenic complex (HNAC), activation of complement and proteinuria appear to be caused by at least one additional antibody species present in anti-Fx1A sera. We have separated by affinity absorption polyspecific antisera against Fx1A and rat microvilli into one IgG fraction directed specifically against microvillar proteins (anti-Fx1A-prot) and another IgG fraction specific for glycolipids (ant-Fx1A-lip) of tubular microvilli. When injected into rats, the anti-Fx1A-prot fraction induced immune deposits but failed to activate complement or produce proteinuria, similar to results obtained with affinity-purified anti-gp330 IgG. When the antibodies of the anti-Fx1A-lip fraction were injected alone they did not bind to glomeruli. By contrast, when the IgGs specific for the Fx1A-prot fraction (or for gp330-HNAC) were combined with those directed against the Fx1A-lip glycolipid preparation, immune deposits were formed, in situ complement activation was observed, and also proteinuria was induced. It is concluded that within anti-Fx1A and anti-microvillar sera there are at least two IgG fractions of relevance for the development of PHN: one directed against the gp330-HNAC complex which is responsible for the development of immune deposits, and a second specific for glycolipid antigen(s) which activate(s) the complement cascade.

Full text

PDF
807

Images in this article

811Figure 2
on p.811
811Figure 3
on p.811
812Figure 4
on p.812
813Figure 5
on p.813
814Figure 6
on p.814
814Figure 7
on p.814
815Figure 8
on p.815
816Figure 9
on p.816
817Figure 10
on p.817

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akerström B., Brodin T., Reis K., Björck L. Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J Immunol. 1985 Oct;135(4):2589–2592. [PubMed] [Google Scholar]
  2. Cybulsky A. V., Rennke H. G., Feintzeig I. D., Salant D. J. Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest. 1986 Apr;77(4):1096–1107. doi: 10.1172/JCI112408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Edgington T. S., Glassock R. J., Dixon F. J. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med. 1968 Mar 1;127(3):555–572. doi: 10.1084/jem.127.3.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gershoni J. M., Palade G. E. Protein blotting: principles and applications. Anal Biochem. 1983 May;131(1):1–15. doi: 10.1016/0003-2697(83)90128-8. [DOI] [PubMed] [Google Scholar]
  5. Hara M., Batsford S. R., Mihatsch M. J., Bitter-Suermann D., Vogt A. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria. Lab Invest. 1991 Aug;65(2):168–179. [PubMed] [Google Scholar]
  6. Heymann W., Kmetec E. P., Wilson S. G., Hunter J. L., Hackel D. B., Okuda R., Cuppage F. Experimental autoimmune renal disease in rats. Ann N Y Acad Sci. 1965 Jun 30;124(1):310–322. doi: 10.1111/j.1749-6632.1965.tb18966.x. [DOI] [PubMed] [Google Scholar]
  7. Kamata K., Baird L. G., Erikson M. E., Collins A. B., McCluskey R. T. Characterization of antigens and antibody specificities involved in Heymann nephritis. J Immunol. 1985 Oct;135(4):2400–2408. [PubMed] [Google Scholar]
  8. Kerjaschki D., Farquhar M. G. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med. 1983 Feb 1;157(2):667–686. doi: 10.1084/jem.157.2.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kerjaschki D., Farquhar M. G. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5557–5561. doi: 10.1073/pnas.79.18.5557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kerjaschki D., Sawada H., Farquhar M. G. Immunoelectron microscopy in kidney research: some contributions and limitations. Kidney Int. 1986 Aug;30(2):229–245. doi: 10.1038/ki.1986.175. [DOI] [PubMed] [Google Scholar]
  11. Kerjaschki D., Schulze M., Binder S., Kain R., Ojha P. P., Susani M., Horvat R., Baker P. J., Couser W. G. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol. 1989 Jul 15;143(2):546–552. [PubMed] [Google Scholar]
  12. Kerjaschki D., Ullrich R., Diem K., Pietromonaco S., Orlando R. A., Farquhar M. G. Identification of a pathogenic epitope involved in initiation of Heymann nephritis. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11179–11183. doi: 10.1073/pnas.89.23.11179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Magnani J. L., Brockhaus M., Smith D. F., Ginsburg V. Detection of glycolipid ligands by direct binding of carbohydrate-binding proteins to thin-layer chromatograms. Methods Enzymol. 1982;83:235–241. doi: 10.1016/0076-6879(82)83016-4. [DOI] [PubMed] [Google Scholar]
  14. Malathi P., Preiser H., Fairclough P., Mallett P., Crane R. K. A rapid method for the isolation of kidney brush border membranes. Biochim Biophys Acta. 1979 Jun 13;554(1):259–263. doi: 10.1016/0005-2736(79)90023-3. [DOI] [PubMed] [Google Scholar]
  15. McLean I. W., Nakane P. K. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem. 1974 Dec;22(12):1077–1083. doi: 10.1177/22.12.1077. [DOI] [PubMed] [Google Scholar]
  16. Michalek M. T., Bremer E. G., Mold C. Effect of gangliosides on activation of the alternative pathway of human complement. J Immunol. 1988 Mar 1;140(5):1581–1587. [PubMed] [Google Scholar]
  17. Michalek M. T., Mold C., Bremer E. G. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid. J Immunol. 1988 Mar 1;140(5):1588–1594. [PubMed] [Google Scholar]
  18. Miettinen A., Törnroth T., Tikkanen I., Virtanen I., Linder E. Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest. 1980 Dec;43(6):547–555. [PubMed] [Google Scholar]
  19. Mold C. Effect of membrane phospholipids on activation of the alternative complement pathway. J Immunol. 1989 Sep 1;143(5):1663–1668. [PubMed] [Google Scholar]
  20. Natorio Y., Hayakawa I., Shibata S. Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats. Am J Pathol. 1989 Feb;134(2):405–410. [PMC free article] [PubMed] [Google Scholar]
  21. Neale T. J., Ullrich R., Ojha P., Poczewski H., Verhoeven A. J., Kerjaschki D. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3645–3649. doi: 10.1073/pnas.90.8.3645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Orlando R. A., Kerjaschki D., Kurihara H., Biemesderfer D., Farquhar M. G. gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6698–6702. doi: 10.1073/pnas.89.15.6698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pietromonaco S., Kerjaschki D., Binder S., Ullrich R., Farquhar M. G. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1811–1815. doi: 10.1073/pnas.87.5.1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pruchno C. J., Burns M. M., Schulze M., Johnson R. J., Baker P. J., Alpers C. E., Couser W. G. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis. Am J Pathol. 1991 Jan;138(1):203–211. [PMC free article] [PubMed] [Google Scholar]
  25. Ronco P., Allegri L., Melcion C., Pirotsky E., Appay M. D., Bariety J., Pontillon F., Verroust P. A monoclonal antibody to brush border and passive Heymann nephritis. Clin Exp Immunol. 1984 Feb;55(2):319–332. [PMC free article] [PubMed] [Google Scholar]
  26. Salant D. J., Darby C., Couser W. G. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest. 1980 Jul;66(1):71–81. doi: 10.1172/JCI109837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schulze M., Baker P. J., Perkinson D. T., Johnson R. J., Ochi R. F., Stahl R. A., Couser W. G. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int. 1989 Jan;35(1):60–68. doi: 10.1038/ki.1989.8. [DOI] [PubMed] [Google Scholar]
  28. Svennerholm L., Fredman P. A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta. 1980 Jan 18;617(1):97–109. doi: 10.1016/0005-2760(80)90227-1. [DOI] [PubMed] [Google Scholar]
  29. Verroust P., Ronco P., Chatelet F. Antigenic targets in membranous glomerulonephritis. Springer Semin Immunopathol. 1987;9(4):341–358. doi: 10.1007/BF00197213. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES